Page 1075 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

4 References

91. Mei Q, Gurunathan S, Masur H, Kovacs JA. Failure of co- 108. Salomon N, Perlman DC, Friedmann P, Buchstein S, Kreiswirth
trimoxazole in Pneumocystis carinii infection and mutations in BN, Mildvan D. Predictors and outcome of multidrug-resistant
dihydropteroate synthase gene. Lancet. 1998;351:1631-1632. tuberculosis. Clin Infect Dis. 1995;21:1245-1252.
92. Helweg-Larsen J, Benfield TL, Eugen-Olsen J, Lundgren JD, 109. Lopez-Cortes LF, Ruiz-Valderas R, Viciana P, et al.
Lundgren B. Effects of mutations in Pneumocystis carinii dihy- Pharmacokinetic interactions between efavirenz and rifampicin
dropteroate synthase gene on outcome of AIDS-associated P. in HIV-infected patients with tuberculosis. Clin Pharmacokinet.
carinii pneumonia. Lancet. 1999;354:1347-1351. 2002;41:681-690.
93. Navin TR, Beard CB, Huang L, et al. Effect of mutations in 110. Cohen K, van Cutsem G, Boulle A, et al. Effect of rifampicin-
Pneumocystis carinii dihydropteroate synthase gene on out- based antitubercular therapy on nevirapine plasma concentra-
come of P carinii pneumonia in patients with HIV-1: a prospec- tions in South African adults with HIV-associated tuberculosis.
tive study. Lancet. 2001;358:545-549. J Antimicrob Chemother. 2008;61:389-393.
94. Smego RA Jr, Nagar S, Maloba B, Popara M. A meta-analysis 111. Bower M, Barton SE, Nelson MR, et al. The significance of the
of salvage therapy for Pneumocystis carinii pneumonia. Arch detection of cytomegalovirus in the bronchoalveolar lavage
Intern Med. 2001;161:1529-1533. fluid in AIDS patients with pneumonia. AIDS. 1990;4:317-320.
95. Helweg-Larsen J, Benfield T, Atzori C, Miller RF. Clinical effi- 112. Bozzette SA, Arcia J, Bartok AE, et al. Impact of Pneumocystis
cacy of first- and second-line treatments for HIV-associated carinii and cytomegalovirus on the course and outcome of
Pneumocystis jirovecii pneumonia: a tri-centre cohort study. atypical pneumonia in advanced human immunodeficiency
J Antimicrob Chemother. 2009;64:1282-1290. virus disease. J Infect Dis. 1992;165:93-98.
96. el-Sadr W, Simberkoff MS. Survival and prognostic factors in 113. Zurlo JJ, O’Neill D, Polis MA, et al. Lack of clinical utility of
severe Pneumocystis carinii pneumonia requiring mechanical cytomegalovirus blood and urine cultures in patients with HIV
ventilation. Am Rev Respir Dis. 1988;137:1264-1267. infection. Ann Intern Med. 1993;118:12-17.
97. Wachter RM, Luce JM, Turner J, Volberding P, Hopewell PC. 114. Rodriguez-Barradas MC, Stool E, Musher DM, et al. Diagnosing
Intensive care of patients with the acquired immunodeficiency and treating cytomegalovirus pneumonia in patients with
syndrome: outcome and changing patterns of utilization. Am AIDS. Clin Infect Dis. 1996;23:76-81.
Rev Respir Dis. 1986;134:891-896. 115. Khoo SH, Denning DW. Invasive aspergillosis in patients with
98. Ronco JJ, Montaner JS, Fenwick JC, Ruedy J, Russell JA. AIDS. Clin Infect Dis. 1994;19(suppl 1):S41-S48.
Pathologic dependence of oxygen consumption on oxygen 116. Staples CA, Kang EY, Wright JL, Phillips P, Muller NL. Invasive
delivery in acute respiratory failure secondary to AIDS-related pulmonary aspergillosis in AIDS: radiographic, CT, and patho-
Pneumocystis carinii pneumonia. Chest. 1990;98:1463-1466. logic findings. Radiology. 1995;196:409-414.
99. Aaron L, Saadoun D, Calatroni I, et al. Tuberculosis in HIV- 117. Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice
infected patients: a comprehensive review. Clin Microbiol Infect. guidelines for the management of patients with histoplasmosis:
2004;10:388-398. 2007 update by the Infectious Diseases Society of America. Clin
100. Perlman DC, el-Sadr WM, Nelson ET, et al. Variation of chest Infect Dis. 2007;45:807-825.
radiographic patterns in pulmonary tuberculosis by degree of 118. Gutierrez ME, Canton A, Sosa N, Puga E, Talavera L.
human immunodeficiency virus-related immunosuppression. Disseminated histoplasmosis in patients with AIDS in Panama:
The Terry Beirn Community Programs for Clinical Research on a review of 104 cases. Clin Infect Dis. 2005;40:1199-1202.
AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG). Clin
Infect Dis. 1997;25:242-246. 119. Baddley JW, Sankara IR, Rodriquez JM, Pappas PG, Many WJ Jr.
Histoplasmosis in HIV-infected patients in a southern regional
101. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. medical center: poor prognosis in the era of highly active
Updated guidelines for using Interferon Gamma Release Assays antiretroviral therapy. Diagn Microbiol Infect Dis. 2008;62:
to detect Mycobacterium tuberculosis infection - United States, 151-156.
2010. MMWR Recomm Rep. 2010;59:1-25.
120. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated
102. Updated guidelines for the use of nucleic acid amplification histoplasmosis in the acquired immune deficiency syndrome:
tests in the diagnosis of tuberculosis. MMWR Morb Mortal clinical findings, diagnosis and treatment, and review of the
Wkly Rep. 2009;58:7-10. literature. Medicine (Baltimore). 1990;69:361-374.
103. Vittor AY, Garland JM, Schlossberg D. Improving the diag- 121. Sarosi GA, Johnson PC. Disseminated histoplasmosis in patients
nosis of tuberculosis: from QuantiFERON to new techniques infected with human immunodeficiency virus. Clin Infect Dis.
to diagnose tuberculosis infections. Curr HIV/AIDS Rep. 1992;14(suppl 1):S60-S67.
2011;8:153-163.
122. Akpek G, Lee SM, Gagnon DR, Cooley TP, Wright DG. Bone
104. Treatment of tuberculosis. MMWR Recomm Rep. 2003;52:1-77. marrow aspiration, biopsy, and culture in the evaluation of
105. Pozniak AL, Miller RF, Lipman MC, et al. BHIVA treatment HIV-infected patients for invasive mycobacteria and histo-
guidelines for tuberculosis (TB)/HIV infection 2005. HIV Med. plasma infections. Am J Hematol. 2001;67:100-106.
2005;6(suppl 2):62-83. 123. Hage CA, Ribes JA, Wengenack NL, et al. A multicenter evalu-
106. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant ation of tests for diagnosis of histoplasmosis. Clin Infect Dis.
tuberculosis as a cause of death in patients co-infected with 2011;53:448-454.
tuberculosis and HIV in a rural area of South Africa. Lancet. 124. Corcoran GR, Al-Abdely H, Flanders CD, Geimer J,
2006;368:1575-1580. Patterson TF. Markedly elevated serum lactate dehydrogenase
107. Zignol M, Hosseini MS, Wright A, et al. Global incidence of levels are a clue to the diagnosis of disseminated histoplasmosis
multidrug-resistant tuberculosis. J Infect Dis. 2006;194:479-485. in patients with AIDS. Clin Infect Dis. 1997;24:942-944.

Section05-O-ref.indd 4 1/20/2015 4:51:22 PM